GI-6100

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameGI-6100
Drug Alias NameGI-6100 (Celgene/GlobeImmune)GI-6108 (Celgene/GlobeImmune)GI-6100 (NantCell)MUC1 inhibitors (NantCell)GI-6100 +[6] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionMucin-1 modulators
TargetsMucin-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlobeimmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlobeimmune IncCelgene CorpNantcell Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A